
Cellari is a clinical AI company that produces, documents, and deploys regulatory approved AI solutions and hardware focused on image-related applications for clinics, pharmaceutical and med-tech companies, and research industries. Their platform, created by clinicians, researchers, and regulatory experts, emphasizes quality, reproducibility, and transparency, designed for fast regulatory approval. Key products include the Cellari annotator for pixel-precise annotations, on-premise hardware for secure data analysis, secure cloud data storage compliant with European regulations, and cloud training capabilities. The platform supports all common image and video formats and enables real-time results extraction once models are trained. Cellari targets clinical and research sectors with a focus on robust, reproducible image science and collaboration through data and AI model sharing within organizations.

Cellari is a clinical AI company that produces, documents, and deploys regulatory approved AI solutions and hardware focused on image-related applications for clinics, pharmaceutical and med-tech companies, and research industries. Their platform, created by clinicians, researchers, and regulatory experts, emphasizes quality, reproducibility, and transparency, designed for fast regulatory approval. Key products include the Cellari annotator for pixel-precise annotations, on-premise hardware for secure data analysis, secure cloud data storage compliant with European regulations, and cloud training capabilities. The platform supports all common image and video formats and enables real-time results extraction once models are trained. Cellari targets clinical and research sectors with a focus on robust, reproducible image science and collaboration through data and AI model sharing within organizations.
Founded: 2018
Headquarters: Frederiksberg, Hovedstaden, Denmark
Sector: Clinical / bioimage AI platform
Seed investors: SOSV, RebelBio
Image-related clinical and research workflows requiring reproducible, regulatory-compliant AI for bioimage segmentation and analysis.
2018
Healthcare / Biotechnology / Medical AI
RebelBio listed among investors
“SOSV and RebelBio participated in seed round”